Ligand validation:8FVD

GTF: 2'-deoxy-2',2'-difluorocytidine 5'-(tetrahydrogen triphosphate)

GTF is a Ligand Of Interest in 8FVD designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
8FVD_GTF_B_701	43%	5%	0.237	0.963	3.81	1.64	13	7	0	0	100%	1
8FVD_GTF_A_602	43%	5%	0.234	0.958	3.8	1.56	13	6	0	0	100%	1
8FV6_GTF_BBB_701	80%	63%	0.138	0.989	0.54	0.85	-	2	0	0	100%	1
8FV7_GTF_BBB_704	75%	62%	0.15	0.983	0.55	0.91	-	3	0	0	100%	1
8FVC_GTF_AAA_603	74%	65%	0.16	0.992	0.56	0.78	-	1	0	0	100%	1
8FV8_GTF_AAA_603	74%	56%	0.154	0.984	0.62	1.07	-	2	0	0	100%	1
8V7C_GTF_A_504	87%	60%	0.086	0.957	0.66	0.88	-	1	2	0	100%	0.85
3MDC_GTF_A_576	68%	3%	0.118	0.928	4.2	1.76	11	7	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.